FutureMS Study Open Nationwide

FutureMS is now open for recruitment throughout Scotland via four participating centres in Aberdeen, Dundee, Edinburgh and Glasgow.

FutureMS is a Scotland-wide study for people recently diagnosed with relapsing-remitting multiple sclerosis. It aims to detect the clinical, laboratory, and genetic factors that affect the severity of MS.

This knowledge will be crucial for the development of tools that help neurologists to give a more accurate and personalised prediction of severity.

The potential impact of FutureMS

Reducing uncertainty: When people are newly diagnosed with MS, they do not know what the future will hold. Most people experience occasional bouts of symptoms called 'relapses', but doctcors cannot predict how often, and how severe, these relapses will be. This can make it difficult for people to make decisions about their lifestyle, work and family. FutureMS will give people with MS greater clarity about what their future holds.

Targeting treatment: By supporting a more accurate prognosis for individuals, FutureMS will also help doctors to prescribe the right medication at the right time for the right person. This is someties called 'personalised medicine'.

Finding out more and getting involved

Further information and an online form to express your interest are available through the FutureMS study website future-ms.org.

This study is funded by Stratified Medicine Scotland Innovation Centre